Press Releases
Statement From Friends of Cancer Research on Monica Bertagnolli’s Nomination as Director of The National Cancer Institute
Friends of Cancer Research (Friends) commends President Joe Biden on nominating Dr. Monica Bertagnolli as the Director of The National Cancer Institute (NCI). As the
Statement on the VALID Act of 2022
Friends of Cancer Research (Friends) applauds the thoughtful work in constructing the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2022 – and particularly for including
New Research Shows Breakthrough Therapy Designated Drugs Provide Maximum Benefit to Patients
A new analysis conducted by Friends of Cancer Research (Friends) published today in Clinical Cancer Research, a journal of the American Association for Cancer Research,
Friends of Cancer Research Statement on the Proposed House and Senate FDA User Fee Legislation
Friends of Cancer Research (Friends) is encouraged by the notable progress being made within the House and Senate on the upcoming reauthorization of the FDA
Dr. Ned Sharpless Stepping Down as National Cancer Institute Director
Friends of Cancer Research (Friends) would like to thank Dr. Ned Sharpless for his tireless public service and scientific leadership as Director of the National
Friends of Cancer Research Statement Thanking Dr. Janet Woodcock for Service as Acting FDA Commissioner
Friends of Cancer Research (Friends) would like to thank Dr. Janet Woodcock for serving as Acting Commissioner of the Food and Drug Administration (FDA) and
Statement from Friends of Cancer Research on Dr. Robert Califf’s Confirmation as FDA Commissioner
Friends of Cancer Research (Friends) would like to congratulate Dr. Robert Califf on his bipartisan confirmation today as FDA Commissioner. The United States is at
Statement from Friends of Cancer Research on President & Dr. Biden’s Cancer Moonshot
Friends of Cancer Research (Friends) would like to congratulate President Biden and Dr. Biden on the announcement of a new Cancer Moonshot. We applaud the
New HRD Publication Sets the Stage for Unique Collaboration
Friends of Cancer Research (Friends) is excited to announce its latest publication “Homologous Recombination Deficiency: Concepts, Definitions, and Assays.” Findings from this manuscript set the
Friends of Cancer Research Announces Results from Phase 2 of Tumor Mutational Burden Harmonization Project
Washington, DC – Friends of Cancer Research (Friends) is pleased to announce findings from the final analysis of our TMB Harmonization Project published this week
